# FDA WARNING_LETTER - Nephron Sc Inc - April 20, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/nephron-sc-inc/fb25266d-0c42-4d39-9684-7eafaa7ba68e

> FDA WARNING_LETTER for Nephron Sc Inc on April 20, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Nephron Sc Inc
- Inspection Date: 2022-04-20
- Product Type: Drugs
- Office Name: Office of Pharmaceutical Quality Operations Division I

## Related Documents

- [WARNING_LETTER - 2020-09-22](https://www.globalkeysolutions.net/records/warning_letter/nephron-sc-inc/528714ca-cb23-40df-ae69-431984f050f7)
- [483 - 2025-08-22](https://www.globalkeysolutions.net/records/483/nephron-sc-inc/138bf3dc-807d-445f-be48-21d4172245a5)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/nephron-sc-inc/6ba73294-ce51-4aee-94cc-baecf85d8183)

## Related Officers

- [Acting Program Division Director](https://www.globalkeysolutions.net/people/frances-de-jesus/b07b8929-85a5-4441-adff-74522fd8466a)

Company: https://www.globalkeysolutions.net/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations-division-i/798d6a62-d1f1-4f7c-8de3-465e277c13da